Hepatitis C - ANGER OVER `LOW-KEY' LIVER REPORT

ANGER OVER `LOW-KEY' LIVER REPORT
Community Newswire, UK - Dec 20, 2005... The report estimates there are currently 4,500 people in the UK living with severe liver disease as a result of having a chronic hepatitis C infection and ...

Human Genome Sciences Reports on Progress Toward Commercialization ...
PR Newswire (press release), NY - Jan 10, 2006... Commercialization - - Plan to Advance LymphoStat-B(TM) to Phase 3 in SLE - - Plan to Advance Albuferon(TM) to Phase 3 in Chronic Hepatitis C - - Working to ...

Keryx Biopharmaceuticals, Inc. Announces Appointment of Senior ...
PR Newswire (press release), NY - Jan 4, 2006... recombinant interferon-alpha 2-b), for the treatment of malignant melanoma, hairy cell leukemia, AIDS-related Kaposi's sarcoma, chronic hepatitis C and chronic ...

Valeant buys InterMune hepatitis C drug
San Francisco Business Times, CA - Jan 3, 2006... company said. Infergen is used to treat adult patients suffering from chronic hepatitis C viral infections with liver disease. Costa ...

Anadys Pharmaceuticals to Initiate 28-Day Clinical Trial of ANA975 ...
Yahoo! News (press release) - Dec 22, 2005... News) announced today that it plans to initiate a Phase Ib, placebo-controlled, multiple-dose clinical trial of ANA975 in chronic hepatitis C patients in ...

Biochemical connection between hepatitis C virus and liver cancer ...
Xagena.it, Italy - Jan 6, 2006... Approximately 200 million people worldwide suffer from chronic hepatitis C, which can persist in the body for decades after an initial infection, often causing ...